• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: Biosense Webster Inc VARIPULSE Bi-Directional Catheter; Percutaneous Cardiac Abl Cath for Treatmt of AFib w Irreversible Electroporation

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

Biosense Webster Inc VARIPULSE Bi-Directional Catheter; Percutaneous Cardiac Abl Cath for Treatmt of AFib w Irreversible Electroporation Back to Search Results
Catalog Number D141201
Medical Device Problem Codes High Readings (2459); Patient Device Interaction Problem (4001)
Health Effect - Clinical Code Respiratory Failure (2484)
Date of Event 07/02/2026
Type of Reportable Event Serious Injury
Event or Problem Description
It was reported that a patient underwent a persistent atrial fibrillation ablation procedure with a varipulse catheter and the patient experienced acute respiratory distress syndrome that required manual ventilation.Two minutes after the error 311 'current too high during ablation' on the trupulse monitor, the o2 of the patient dropped to 60%.The nurses had to manually ventilate the patient as she was not breathing properly anymore.After 2-3 minutes the o2 saturation recovered back to 90%.The procedure was successfully completed.In the physician¿s opinion this happened due to the sedation with propofol.
 
Additional Manufacturer Narrative
Device investigation details: an analysis of the product could not be performed since a physical sample was not received for evaluation.However, if the product is received at a later date, the investigation will be updated as applicable.A manufacturing record evaluation was performed for the finished device number lot 31840413l and no internal action related to the complaint were found during the review.As part of our company quality system process, all devices are manufactured, inspected, and distributed to approved specifications.This report is being submitted pursuant to the provisions of 21 cfr, part 803.This report may be based on information which has not been investigated or verified prior to the required reporting date.This report does not reflect a conclusion by biosense webster inc., or its employees that the report constitutes an admission that the product, biosense webster inc., or its employees caused or contributed to the potential event described in this report.If information is obtained that was not available for the initial report, a follow-up report will be filed as appropriate.Manufacturer's ref.# (b)(4).
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
VARIPULSE Bi-Directional Catheter
Common Device Name
Percutaneous Cardiac Abl Cath for Treatmt of AFib w Irreversible Electroporation
Manufacturer (Section D)
Biosense Webster Inc
31 technology drive, suite 200
irvine CA 92618
Manufacturer (Section G)
Biosense Webster Inc (Juarez)
circuito interior norte
1820parque industrial salvacar
juarez 32599
MX   32599
Manufacturer Contact
katie seppa
31 technology dr
irvine, CA 92618
+1(513)337-8052
MDR Report Key50094395
Report Number3013300026-2026-02466
Device Sequence Number21333536
Product Code QZI
UDI-Device Identifier10846835025460
UDI-Public(01)10846835025460(17)270122(10)31840413L
Combination Product (Y/N)N
Initial Reporter CountryUS
PMA/510(K) Number
P240006
Number of Events Summarized1
Summary Report (Y/N)N
Reporter Type Manufacturer
Report Source Foreign,Health Professional,Company Representative
Type of Report Initial,Followup,Followup
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Operator of Device Health Professional
Device Catalogue NumberD141201
Device Lot Number31840413L
Was Device Available for Evaluation? Yes
Date Returned to Manufacturer08/05/2026
Is the Reporter a Health Professional? No
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer 07/03/2026
Supplement Date Received by Manufacturer08/05/2026
08/11/2026
Initial Report FDA Received Date07/31/2026
Supplement Report FDA Received Date08/11/2026
08/30/2026
Was Device Evaluated by Manufacturer? (Y/N) Yes
Date Device Manufactured01/23/2026
Is the Device Labeled for Single Use? (Y/N) Yes
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Outcome Attributed to Adverse Event Life Threatening; Required Intervention;
Patient SexUnknown
-
-